Log in
Register
SearchProduct-specific advice (steroid nasal sprays) [Design Issues]
Hello Mikalai,
» Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids?
There is nothing specific yet but they are working on it.
» More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.
You need a scientific advice. There are a ton of companies selling in vitro tests in various flavours and colors and the best I can say of them is that without a scientific advice each and every of those tests may from a regulatory perspective be as good as the south end of a nort-bound horse.
» Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids?
There is nothing specific yet but they are working on it.
» More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.
You need a scientific advice. There are a ton of companies selling in vitro tests in various flavours and colors and the best I can say of them is that without a scientific advice each and every of those tests may from a regulatory perspective be as good as the south end of a nort-bound horse.
—
Best regards,
ElMaestro
“(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures.” New York Times (ed.), June 9, 2018.
if (3) 4
x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1Best regards,
ElMaestro
“(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures.” New York Times (ed.), June 9, 2018.
Complete thread:
- Product-specific advice (steroid nasal sprays) Mikalai 2018-10-16 13:42 [Design Issues]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Product-specific advice (steroid nasal sprays) ElMaestro 2018-10-16 20:35
- Product-specific advice (steroid nasal sprays) Mikalai 2018-10-17 09:40
- Product-specific advice (steroid nasal sprays) ElMaestro 2018-10-17 11:56
- Product-specific advice (steroid nasal sprays) Mikalai 2018-10-17 09:40
- Product-specific advice (steroid nasal sprays) ElMaestro 2018-10-16 20:35
Ing. Helmut Schütz